Introduction
The 14 kDa human immunodeficiency virus type 1 (HIV-1) accessory protein, viral protein R (Vpr) , has received significant attention due to its regulatory effect upon virus and host functions (le Rouzic and Benichou, 2005) . At the cellular level, expression of Vpr results in deregulation of the cell cycle and accumulation of cells at the G 2 /M stage of the cell cycle, which leads to their death by apoptosis (Goh et al., 1998; Sawaya et al., 1999; Tachiwana et al., 2006) . Vpr can induce apoptosis through a variety of mechanisms (Jacotot et al., 2000; Patel et al., 2000; Stewart et al., 2000) . In one study, suppression of nuclear factor-kB (NF-kB) activity through the induction of IkB was linked to Vprmediated apoptosis (Ayyavoo et al., 1997) . In other studies, induction of apoptosis by Vpr was attributed to rapid dissipation of the mitochondrial transmembrane potential, association of Vpr with the adenine nucleotide translocator, release of cytochrome c and activation of caspase-3 (Jacotot et al., 2000) . Finally, Vpr-induced apoptosis has been shown to require the activation of caspase-8 (Patel et al., 2000) , and be part of a pathway involving hHR23A (Gaynor and Chen, 2001) . Vpr was also shown to induce cell death in rat astrocytes primarily by a necrotic mechanism (Huang et al., 2000) . Vpr exerts a transcriptional activation function in cells infected with HIV-1 similar to VP16 of Herpes simplex virus (Sherman et al., 2002) . Vpr can induce several promoters, including the HIV-1 LTR and p21 WAF1 (Wang et al., 1995; Amini et al., 2004) . These studies suggest that cooperativity between several cellular proteins including Sp1 (Wang et al., 1995) , p300 (Kino et al., 2002) and p53 (Sawaya et al., 1998) is necessary for Vpr-induced regulation of the HIV-LTR. Vpr was also shown to cause cell differentiation and DNA damage (Shimura et al., 1999a, b) . In those reports, the authors demonstrated that Vpr induced chromosomal aberrations and gene amplification, but the domain(s) and mechanism(s) by which Vpr induced these anomalies were not identified. In a recent study, the same group demonstrated that Vpr induces double-strand breaks (DSBs) in HIV-1-infected cells (Tachiwana et al., 2006) . However, the Vpr domain responsible for this damage or DNA break was not identified.
Here, we identify the region spanning aa 37-50 within the full-length Vpr as a causative factor in the induction of a number of insults to the genome. The DNA of telomeric region is most likely involved in the DNA double-strand damage and rejoining, chromosomal numerical and structural aberrations, cell cycle arrest and apoptosis in cultured U87-MG cells. Furthermore, the 37-50 domain of wild-type (wt) Vpr induced chromosomal anomalies and exhibited molecular mimicking to cisplatin, an anticancer alkylating drug.
Results
Several studies implicate Vpr in DNA damage; however, the precise domain within Vpr involved in this damage has not yet been elucidated (Tachiwana et al., 2006) . Using cytogenetic analysis, we examined the DNAdamaging effect of a specific domain of Vpr. U-87MG cells were transfected with Vpr expression plasmid, treated with colcemid, lysed in hypotonic buffer and fixed (Siddiqui et al., 1988) . As a positive control, cisplatin, an anticancer alkylating agent was used. As shown in Figure 1a , cisplatin as well as Vpr induced DNA perturbation and structural chromosomal aberrations. The commonly noted aberrations are: quadriradial and formation of complex configurations of chromosomes (panels 1), ring, pulverized and dicentric chromosomes (panels 4). In addition, some metaphases exhibited chromosomes with amplified genes, for example, the presence of double minute chromosomes and stretched chromosomes . These abnormalities involve DNA breaks and end rejoining in a complex pattern. Some aberrations, especially the formation of complex configurations and dicentric chromosomes, are similar to aberrations induced by cisplatin (compare Vpr panels to cisplatin panels). No chromosomal anomalies were observed in the control cultures (Control panel). This suggests molecular mimicking between a biological entity (Vpr) and a chemical agent (cisplatin). The number of chromosomal aberrations and the type of aberrations are summarized in Figure 1b .
In the next set of experiments, we sought to identify the domain within Vpr responsible for DNA damage. Several Vpr mutants containing either point mutations or deletion of several amino acids were used (Wang et al., 1995; Sawaya et al., 1998 Sawaya et al., , 1999 Zhou and Ratner, 2000 into U-87MG and subjected to cytogenetic analysis. As shown in Figure 2a , mutant Vpr induced DNA perturbation and structural chromosomal aberrations. These aberrations are similar to the ones observed with the full-length Vpr (compare Figure 2a to Figure 1a) . Interestingly, only mutant , in which amino acids 37-50 were deleted, did not produce chromosomal aberrations (Figures 2a and b) . It should be noted that this region (aa 37-50) was previously shown to form the helical domain II of Vpr (Wecker et al., 2002) . Previously, using MIT-23 cells, Tachiwana et al. (2006) demonstrated that the C-terminal domain of Vpr is involved in Vpr-induced DNA DSBs . Thus, we sought to examine the ability of this particular mutant to cause DNA damage. Using, Vpr HxB2 in which 23 aa from the C-terminal domain were deleted (Mahalingam et al., 1995) , we observed that the most common anomalies caused by HxB2 were clumped metaphases, separated sister chromatids at kinetochore region, and metaphases with dumbbell-shaped chromosomes (Figure 2a, HxB2 panel) . These anomalies indicate that no chromosomal break and rejoining occurred. These results led us to suggest that the C-terminal domain of Vpr is not involved in DNA damage and that the results obtained with this mutant in MIT-23 cells may be cell type-specific.
The inability of to cause DNA damage led us to examine its stability and subcellular localization.
Using western blot analysis, U-87MG cells were transfected with Vpr (wt or mutant) expression plasmids. Figure 3a shows expression of transfected Vpr. Grb2 was the loading control. This experiment confirmed the expression and stability of protein.
Next, U-87MG cells were infected with adeno-Vpr (full length or mutant). Uninfected or adeno-null infected cells were also used as controls. 4 0 ,6 0 -Diamidino-2-phenylindole hydrochloride (DAPI) staining was used to visualize nuclei (blue). As shown in Figure 3b , Vpr (red) is found in the nucleus and the cytoplasm. A similar localization was observed with . Therefore, we concluded that both wt and mutant-Vpr proteins have a similar subcellular distribution.
The ability of wt Vpr to activate HIV-1 transcription led us to determine the functional ability of . U-87MG cells were transfected with fulllength LTR-CAT reporter gene construct, alone or in the presence of Vpr expression plasmid. As shown in Figure 3c , transfection of Vpr D(37-50) activated HIV-LTR 5.12-fold, that is similar to wt Vpr.
Next, we examined whether Vpr D(37-50) possesses the ability to cause cell cycle arrest at the G 2 /M checkpoint (Goh et al., 1998) and methods (Sawaya et al., 2000) . The cells transfected with expression vectors encoding wt Vpr exhibited cell cycle arrest in the G 2 /M (58.7%) of the cell cycle. However, the mutant Vpr was unable to induce cell cycle arrest in G 2 /M (Figure 3d ). Thus, like wt Vpr, Vpr D(37-50) is a stable protein, has the ability to activate HIV-LTR and is found in the nucleus and cytoplasm. However, it is unable to cause cell cycle arrest. In preparation for cell division, nuclear chromatin undergoes critical rearrangement needed for the organization of chromosomes and their separation into daughter cells. These chromatin changes are initiated during G 2 phase of the cell cycle, and their most striking morphological manifestation is chromatin condensation (Hans and Dimitrov, 2001 ). Phosphorylation of histone H3 is highly correlated with the G 2 to M transition. In mitotic cells, H3 is specifically phosphorylated at serine 10 (S10) near its N terminus (Nowak and Corces, 2004) . H3 dephosphorylation occurs rapidly after mitosis and S10 remains unphosphorylated throughout the remainder of interphase (Juan et al., 1998) . Therefore, to further confirm that the Vpr-infected cells are in G 2 and not in mitotic phase, we performed western analysis. U-87MG cells were synchronized and then infected with adeno-null, adeno-Vpr or adeno-Vpr D(37-50) viruses. Noninfected (mock) cells were used as a control. Cells were collected every 2 h, and nuclear extracts were prepared and subjected to western analysis using anti-cyclin B1 or antibody that recognizes H3 phosphorylated on S10. Note that this experiment was performed in duplicate where one set was subjected to cell cycle analysis (data not shown) and the other set was subjected to western blot analysis. As shown in Figure 4a , no changes were observed in the levels of cyclin B1 in Vpr-infected cells, which points to the accumulation of cyclin B1 in G 2 phase (left panels, adeno-Vpr row). Interestingly, S10-phosphorylated H3 was barely detectable in Vpr-infected cells (middle panels, Vpr row). These data confirm that the cells are in G 2 and almost no cells progressed to the M phase. Involvement of the helical domain II of Vpr in DNA damage K Siddiqui et al Phosphorylated S10 of H3 was detected in mock, adenonull and adeno-Vpr D(37-50)-infected cells, which means that these cells progress from G 2 to M phase (middle panels, Mock, ad-null, ad-Vpr D(37-50) rows). Grb2 was the loading control (right panels).
The data described in Figure 1 showed Vpr causes several types of aberrations including chromosomal rearrangements and fusions. Fusions take place at the ends of the chromosome, which when lacking telomeric repeats are liable for end-to-end fusion and exonucleolytic degradation. Such events could affect the status of telomeric proteins, for example Ku (de Lange, 2002) . Ku is a component of the nonhomologous end-joining (NHEJ) DNA repair pathway. Therefore, we sought to determine Ku status in Vpr-transfected cells. Extracts prepared from Vpr-or Vpr D(37-50)-transfected U-87MG cells were subject to western blot analysis using anti-Ku70 and -Ku80 antibodies. As shown in Figure 4b , Ku70 and Ku80 proteins were induced by Vpr (compare lanes 1 and 3) . Transfection of the empty plasmid pcDNA 3 alone or of Vpr D(37-50) did not affect Ku70 or Ku 80 (compare lane 1 to lanes 2 and 4). Grb2 was used as the loading control.
Next, we evaluated the effect of Vpr on NHEJ DNA. NHEJ is a quick but nonspecific way to ligate DSBs, which may introduce mutations into the repaired DNA. We used a cell-free assay to evaluate NHEJ DNA in Vpr-transfected cells (Trojanek et al., 2003) . Figure 4c illustrates the formation of multiple bands from the linear plasmid substrate DNA as a result of NHEJ. A significant reduction in the efficiency of NHEJ was observed in the presence of nuclear extracts from U-87MG-expressing Vpr (lane 3). Densitometry analysis (Figure 4d ) was performed for the linear plasmid, dimers and trimers, respectively. The intensity of dimers was reduced more than twofold and the intensity of trimers by sixfold when Vpr-expressing cells were compared to Vpr D(37-50)-transfected U-87MG cells or to the control cells.
In the next set of experiments, we used an animal model of breast cancer to investigate the cytopathic effects of Vpr on tumor growth. After subcutaneous inoculation and growth of MCa-35 mouse mammary cancer cells, the tumors were treated with Vpr, mutant Vpr D(37-50) or serum as control. Note that only a single treatment with Vpr protein was administered. Figure 5b . In the margins of these necrotic areas, the neoplastic cells display nuclear picnosis and fragmentation, which despite the differences in the amount of necrosis, are similar in the treated and control tumors.
Immunohistochemical studies show the absence of Vpr in the control tumors, and the presence of Vpr in the nuclei and cytoplasm of the treated tumor, with a particularly robust expression in the nuclei (Figure 5c , upper panels). Cytochrome c was detected in the margin of the necrotic areas in both, the treated and control tumors; however, its detection appears to be increased in the Vpr-treated tumors (middle panels). Finally, in order to demonstrate the mechanism of cell death, we performed terminal transferase dUTP nick end labeling assays to show the presence of apoptosis. Interestingly, the number of apoptotic cells is remarkably similar, and low between the treated and control tumors (data not shown). However, immunohistochemistry lacking a primary antibody and allowing the nonspecific secondary antibody to penetrate through the damaged membrane of cells undergoing necrosis or necrotic) highlighted the significantly larger areas of necrosis in the Vpr-treated tumors (lower panels).
Vpr contains three amphipathic a-helices connected by loops and folded around a hydrophobic core. Two hydrophobic and hydrophilic domains located on helices I and III of Vpr remain accessible to the solvent. These accessible domains may be involved in proteinprotein and/or protein-nucleic acid interactions (Wecker et al., 2002; Morellet et al., 2003) .
To the understand Vpr D(37-50) activities, a model based on the Vpr wt structure has been constructed. The (37-50) domain was removed from the wt Vpr structure (Morellet et al., 2003) and the (1-36) and (51-96) domains were linked together (Figures 6a and c) . The NMR distance restraints corresponding to the (1-34) (Figures 6b and c) . Thus, it appears that the amino acids between positions 37 and 50, such as tryptophan (W38), histidine (H40), glutamine (Q44), glutamic acid (E48) and tyrosine (Y49), hanging at the periphery of the loop might be more involved in interacting with telomeric DNA, telomerase and/or nucleoproteins. Taken together, these findings lead us to postulate that the sequences spanning aa 37-50 within the wt Vpr may provide opportunities for cancer chemoprevention, treatment of AIDS and a number of other diseases for which effective therapy is not available. 5  10  15  20  25  30  35  40  45  50  55  60  65  70  75  80  85  90  95   MEQAPEDQGPQREPYNDWTLELLEELKNEAVRHFPRIWLHSLGQHIYETYGDTWTGYEALIRILQQLLFIHFRIGCRMSRIGIIQQRRTRNGASKS   1  5  10  15  20  25  30  35  40  45  50  55  60  65  70  75  80  85  90  95 
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Discussion
In this study, we identified the Vpr domain(s) involved in DNA damage. We examined several Vpr mutants and demonstrated that the region encompassing amino acids 37-50 within this viral protein is responsible for this function. We found that Vpr D(37-50) is a stable protein and has the ability to activate HIV-1 gene expression while removal of residues 37-50 from Vpr renders it unable to cause cell cycle arrest. Interestingly, Vpr retains its ability to cause DNA damage in the absence of its C-terminal domain. Note that the C-terminal domain of Vpr has been found to be responsible for cell cycle arrest (Mahalingam et al., 1997a; Zhou et al., 1998) . Truncation of, or amino acid substitution in this region results in failure of induction of cell cycle arrest (Mahalingam et al., 1997a; Zhou et al., 1998) . Mutation analysis indicated that induction of G 2 arrest depended particularly on the isoleucine residues at positions 74 and 81 in the putative leucine zipper-like domain (Nishizawa et al., 1999) . Five of the six Vpr mutations in this region affected G 2 arrest; H71R, H78R and R88K reduced G 2 arrest, while S79A and R90K enhanced G 2 arrest . We conclude that, in order to cause cell cycle arrest, Vpr requires the presence of helical domains II and III. In most cells, Ku proteins (70 and 80) are located in the nucleus where they play a role in NHEJ, which is involved in DSB repair (Labhart, 1999; de Lange, 2002) . Two DSBs on the same DNA molecule lead to the excision of the internal fragment, which can be deleted, inverted or translocated. Among the different rearrangements, deletions are two-to eightfold more frequent than inversion. This may be due in part to the fact that deletion and inversion require one and two ligation events, respectively (Guirouilh-Barbat et al., 2004) . Our results demonstrated that only full-length Vpr affects Ku endogenous levels and disturbs Ku's protective role by preventing NHEJ. This finding correlates with the previously described results in the literature (Majone and Jeang, 2000) , where it has been found that HTLV-1 Tax protein interferes with the protective cellular mechanism(s) used normally for stabilizing DNA breaks and affects Ku80 endogenous levels as well NHEJ (Majone and Jeang, 2000; Majone et al., 2005) . Thus, we concluded that involvement of viral proteins in DNA damage is not without a precedent.
Besides NHEJ, induction of Ku70 and Ku80 also leads to their translocation and involvement with Bax protein to trigger the apoptotic pathway (Muller et al., 2005) . Thus, one can speculate that in addition to DNA damage, Vpr may use Ku family members to trigger the mitochondrial apoptotic pathway. This correlates with observations described previously, where it was reported that HIV-1 uses the pro-apoptotic abilities of Vpr as a strategy to escape immune attack (Gougeon, 2003) . However, the exact mechanisms used by Vpr to cause such damage are not fully understood. One possibility is that it is mediated through the physical interaction between Vpr and hHR23A, a protein involved in DNA repair (Gragerov et al., 1998) . We previously reported that association of Vpr with hHR23A promotes the dissociation of hHR23A-S5A complex (Hiyama et al., 1999) . Once released, the proteasome subunit, S5A, triggers the DNA damage pathway (BE Sawaya, unpublished data) . This observation is in accordance with the study performed by Zhu et al. (2001) , where they demonstrated that hHR23A inhibits the transcriptional activity of p53 and results in a decreased steadystate protein level of cellular p53. The inhibitory effect of hHR23A was neutralized by the coexpression of Vpr.
The ability of Vpr to affect tumor growth is not without precedent. Studies have demonstrated that Vprtransfected melanoma cells inoculated into syngenic C57BL/6 mice showed a markedly reduced ability to form tumors in vivo (Mahalingam et al., 1997b) . These results led the authors to suggest that Vpr has tumor suppressor effects, likely mediated by transcriptional regulation of host cell gene expression. In another study, using AT-84 oral cancer cells to create oral squamous cell carcinomas, a single intratumoral injection of the Vpr lentiviral vector was proven to significantly reduce the primary tumor volume and also regressed tumors in more then 40% of animals (Pang et al., 2001) . Further, our results with regard to the inhibition of tumor growth are similar to the data reported by other investigators utilizing subcutaneous B16 melanoma tumor model. McCray et al. (2006) used electroporation to introduce plasmid DNA expressing Vpr into tumor cells. In addition to the striking tumor growth inhibition, we also observed necrotic areas in the tumors upon histological analysis. This observation is markedly different from earlier studies reported. We are of the opinion that the differences noted might be related to the experimental setting, such as the use of recombinant Vpr protein, mode of delivery and the use of a different model system. The necrotic region may result from the changes in cells via a combination of endogenous and Vpr-induced cytotoxicity. As Vpr has been shown to enter cells (Henklein et al., 2000; Sherman et al., 2001; Nakamura et al., 2002) , it is possible that the necrotic regions may result from spreading of Vpr from the site of inoculation.
Using molecular dynamic simulations, we constructed a model of Vpr D(37-50), which could help to understand the biological activity of this mutant when compared to the full-length protein. It has been shown that residues (15-34) and (54-78) within the full-length Vpr adopt and a-helix structure in the (1-51) Vpr and (52-96) Vpr domains, respectively (Schuler et al., 1999; Wecker and Roques, 1999) . We consider it likely that these residues will adopt the same conformation in . Therefore, in order to maintain the a-helix conformations in , the NMR restraints corresponding to the (1-34) and (54-96) regions, previously used to determine the full structure of Vpr, were introduced in these calculations (Morellet et al., 2003) . In wt Vpr, the hydrophobic domains of the first and third helices, constituted respectively by the Leu20, Leu23, Leu26, Ala30, Val31 and Val57, Leu60, Ile61, Leu64, Leu68, Phe72 residues, interact to each others, in order to maintain the three-dimensional structure of the Involvement of the helical domain II of Vpr in DNA damage K Siddiqui et al protein. The probability that these two hydrophobic domains interact in Vpr D(37-50) is very high (Figure 6c ). In the proposed model (Figure 6c) , the acidic residues of Vpr, located in the first helical domain (Asp17, Glu21, Glu24, Glu25, Asn28 and Glu29) remain accessible for interactions with components of the cellular machinery. In fact, the residues Leu20, Leu23, Leu26, Ala30, Val31 and Val57, Leu60, Ile61, Leu64, Leu68, Phe72 residues located respectively on helix I and helix II in Vpr D(37-50) and in helix I and helix III in Vpr interact to each other to promote the threedimensional structure of Vpr. These residues are not thus accessible for other interactions. On the contrary, the hydrophobic residues, Trp18, Leu22, Leu26 and Ile63, Leu67, Ile70, Ile74 located on helix I and II respectively remain accessible to the solvent. The hydrophilic accessible domains are constituted by the acidic residues Asp17, Glu21, Glu24, Glu25, Asn28, Glu29 on helix I, and by basic residues Arg62, Arg73, Arg77 and Gln65, Gln66 on helix II and Arg80, Arg87, Arg88, Arg90, Lys95. These residues are still accessible for interaction with other proteins.
The probability that these two hydrophobic domains interact in Vpr D(37-50) is very high. Therefore, we proposed two possible models for . Either the one shown in Figure 6c , where the N-and the Cterminal domains do not interact or where they interact and form a leucine zipper between helices I and II of Vpr D(37-50), and in this case the N-and the C-terminal domains, known as acidic and basic domains can interact with each other. Further, the basic residues of the C-terminal domain of Vpr D(37-50) could interact with the acidic residues of the N-terminal domain, which could explain its inability to cause G 2 arrest. In addition, it has been found that the C-terminal basic region of Vpr was critical for Vpr-DNA or Vpr-RNA interactions (Tachiwana et al., 2006) . Therefore, the intermolecular interactions between the basic residues of the C-terminal domain of and the DNA may compete with the intermolecular interactions between the basic and acidic residues of the C-and N-terminal domains, respectively. This competition and interaction could be implicated in the DNA damage.
Our cytogenetic data revealed that one of the main targets of the helical domain II of Vpr, and also cisplatin in the treated cultures, is the telomeric region. For instance, the terminal breakage and rejoining, due to the DNA double-strand break at the telomeres, were exhibited in the formation of dicentric, quadriradial and complex configurations of the chromosomes. It is well known that telomeres, which are made of multiple repeats of (TTAGGG)n, play a pivotal role in the structural integrity and stability of chromosomes (Baumgartner and Lundblad, 2005) . Therefore, any deletion, damage or deterioration of any of telomeres will not only activate the cell cycle arrest check point, but also will induce the genomic instability, structural disintegration of chromosomes and eventually aneuploidy. Aneuploidy is one of the commonly found chromosomal anomalies in most of the solid tumors. Furthermore, metaphases with separated sister chromatides and diplochromosomes in both Vpr and cisplatin indicate that the molecular insult was not limited to the double-strand DNA break and rejoining at the telomeres, but could also implicate other associated proteins during the cell division. In the light of this molecular mimicry between Vpr and cisplatin, which is exhibited at the chromosomal level, we are contemplating to elucidate the precise interaction of Vpr with nuclear proteins especially telomerase. Since considerable data are available on the DNA alkylation and protein-binding characteristics of cisplatin, it would be very interesting to determine the molecular nature of interaction of Vpr with nuclear proteins in a similar manner.
In summary, we have found that the 37-50 aa sequence of full-length Vpr is involved in DNA damage, disrupted the cell cycle and exhibited a molecular mimicry to cisplatin. In view of these observations, it will be important to further investigate the significance and therapeutic implication of this Vpr domain (37-50), especially for chemoprevention of cancer, AIDS and other pathologies.
Materials and methods
Plasmids, cell culture and transfection assays
The pcDNA 3 -Vpr full length and its deletion mutants, EGFPSpectrin, EGFP-Vpr and HIV-LTR-CAT constructs were described previously (Sawaya et al., 1998 (Sawaya et al., , 1999 (Sawaya et al., , 2000 . The human astrocytic cell line, U-87MG, was maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS) and supplemented with antibiotics. Cells were transfected with 0.5 mg of reporter plasmid (HIV-LTR-CAT) or co-transfected with 1 mg of various expression plasmids as described previously (Amini et al., 2005) . The amount of DNA used for each transfection was normalized with pcDNA 3 vector plasmids. Each transfection was repeated multiple times with different plasmid preparations. Cell extracts were prepared 48 h after transfection, and CAT assays were performed as described previously (Sawaya et al., 1998) .
Cell cycle analysis U-87MG cells were transfected with EGFP-spectrin and/or Vpr (wt and mutant) expression plasmids by the calcium phosphate precipitation method (Sawaya et al., 1998) . At the indicated times following transfection, the cells were collected. The EGFP-positive and -negative cells were pelleted and resuspended in 70% ice-cold ethanol for 30 min. Following a wash with phosphate-buffered saline (PBS) containing 1% fetal bovine serum, the cells were incubated in PBS containing RNase A (50 mg/ml) and propidium iodide (40 mg/ ml) for 30 min at 371C. The cellular DNA content was analysed with a FACS scan apparatus. The DNA profile was analysed by the Multicycle AV program (Phoenix Flow System, San Diego, CA, USA).
Western blotting U-87MG cells were transfected with Vpr (wt and mutant) expression plasmids. Forty-eight hours posttransfection, 50 mg of cell extracts were subjected to western blot analysis using anti-Vpr, anti-cyclin B1 or anti-phosphorylated histone H3 (S10) antibodies. Anti-Grb2 antibody was used as a proteinloading control (Claudio et al., 2006) . Cytogenetic assays and chromosomal aberrations U-87MG cells were transfected with 1 mg of plasmids encoding full-length Vpr or its deletion mutants for 48 h. Two hours before termination of the experiments, Colcemid (0.1 mg/ml) was dispensed in each culture. Metaphases were collected and hypotonized in 75 mM KCl for 5-10 min. After which the cells were fixed in methanol: acetic acid (3 : 1, v/v) for 5-10 min. The air-drop method was used to spread the chromosomes on a glass slide (Siddiqui et al., 1988) . Air-dried slides were subsequently stained with Giemsa (10%) for 10 min, and mounted on Permount. All the slides were observed under a Zeiss light microscope using Â 100 objective lens. However, selected photomicrographs were taken under a Nikon light microscope using Â 100 objective lens. For positive control, cells were treated for 18 h with 1.5 mg/ml cisplatin, an alkylating agent known to cross-link with DNA, and consequently induce DNA damage and chromosomal aberrations, and treated as described above.
Recombinant adenoviruses and infection
Full-length and deletion mutant Vpr were amplified by PCR and cloned into the BamHI/HindIII sites of pDC516 under the control of the murine cytomegalovirus promoter. Adeno-Vpr recombinant plasmids containing Vpr sequences (full length and mutant) were transfected into HEK-293 cells with pBHGfrt (del) E1, 3FLP, a plasmid that provides adenovirus type-5 genome deleted in E1 and E3 genes. Plaques of recombinant adenovirus arising as a result of frt/FLP recombination were isolated, grown and purified by cesium chloride density equilibrium banding. Empty shuttle plasmid, pDC515, was used to construct control adenoviral vector (Adeno-null, a virus without any transgene). U-87MG cells were infected with adenoviral vectors at a multiplicity of infection of 5 PFU/cell. After 24 h, the cells were washed and prepared for immunocytochemistry.
Immunocytochemistry
Cells were plated on poly-L-lysine-coated glass chamber slides and allowed to attach overnight. U-87MG cells were transfected with 1 mg of Vpr (wt or mutant) expression plasmid. Cells were then fixed for 3 min in ice-cold acetone, followed by washing with PBS. After blocking with 2% normal rabbit serum for 2 h, slides were incubated in primary antibody (Vpr) overnight at room temperature. Cells were then washed in PBS, incubated in anti-rabbit fluorescein isothiocyanate-conjugated secondary antibody for 2 h at room temperature in the dark, rinsed with PBS and mounted in an aqueous mounting medium (Vector Laboratories, Burlingame, CA, USA) (Claudio et al., 2006) .
Preparation of bacterially expressed Vpr
Plasmid pGEX-2T-Vpr (full length and deletion mutant) fusion proteins were prokaryotically expressed and purified as described previously (Mameli et al., 2007) . Briefly, bacteria containing the expression plasmids were grown to an OD 600 of 0.6 and induced with 300 ml isopropyl-b-D-thiogalactoside (1 M) for 90 min at 371C. Protein extract was prepared and the fusion protein was purified with glutathione agarose beads and eluted with freshly made 50 mM Tris (pH 7.4) containing 15 mM glutathione. Next, 10 ml of thrombin solution (10 cleavage units) was mixed with eluted fusion proteins at 221C for 16 h. Glutathione S-transferase (GST) was then removed by removing glutathione by extensive dialysis (2000 volumes) against 1 Â PBS followed by column purification on Glutathione Sepharose 4B. The integrity and purity of the GST fusion proteins were analysed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by Coomassie blue staining. Known amounts of bovine serum albumin were included as control on the same gel. For long storage at À701C, glycerol was added to a final concentration of 10%.
Mice tumors A total of 6 Â 10 5 of mouse mammary carcinoma (MCa-35) cells were injected into the mammary fat pad of C3H/HeJ female mice. After the tumors reached 1.5 cm 3 , Vpr protein was injected into the center of the tumors with a 30-gauge needle at a dose of 1 mg/kg. Controls were untreated tumors and tumors injected with VprD(37-50). Five days post-treatment, the tumors were surgically removed and placed into a 10% formalin solution for further processing. Sections of 4 mm in thickness were cut and placed in electromagnetically charged slides and H&E staining was performed for routine histological evaluation.
Histology and immunohistochemistry
After euthanasia, tumors were removed, fixed in formalin and embedded in paraffin. Sections of 4 m in thickness were cut and stained with H&E for routine histological analysis. Immunohistochemistry was perfomed using the avidin-biotin-peroxidase technique, according to the manufacturer's instructions (Vector Laboratories). After deparaffination and hydration through alcohol and water, sections were placed in citrate buffer (pH 6.0) at 951C for 30 min for nonenzymatic antigen retrieval and treated with H 2 O 2 in methanol for endogenous peroxidase quenching. Sections were then blocked with normal goat serum and incubated with a rabbit polyclonal anti-Vpr or a mouse monoclonal anti-cytochrome c antibody overnight. After rinsing with PBS, sections were incubated with a goat anti-rabbit or anti-mouse biotinylated secondary antibody for 1 h, then with avidin-biotin-peroxidase complexes (ABC Kit, Vector Laboratories) and then sections were developed with diaminobenzidine (Sigma, St Louis, MO, USA), and finally sections were counterstained with hematoxylin and mounted.
Nonhomologous end joining
The cell-free NHEJ assay was followed (Labhart, 1999) , and nuclear lysates were prepared as previously described (Trojanek et al., 2003) . Briefly, NHEJ reactions were performed in the following conditions: 50 mg of nuclear lysate; 1 mM ATP; 0.25 mM dNTPs; 25 mM Tris-acetate (pH 7.5); 100 mM potassium acetate; 10 mM magnesium acetate; and 1 mM dithiothreitol. After 5 min of preincubation at 371C, the reaction mixture was supplemented with the substrate (500 ng of XhoI-XbaI linearized pBluescript KS þ ). The reaction was incubated for 1 h at 371C to ligate the plasmid and treated with proteinase K to digest DNA-bound proteins. Products of the NHEJ reactions were resolved in 0.6% agarose gel containing 0.5 mg/ml of ethidium bromide.
NMR structure
Calculations were performed with the Discover/NMRchitect software package from Accelrys with the Amber forcefield using a dielectric constant, e ¼ 4r, in order to diminish in vacuo electrostatic effects. Fifty initial structures for were generated using simulated annealing, followed by energy minimization until a maximum gradient value of 0.01 kcal/ mol/Å under NMR restraints determined for wt Vpr. The restraints found for the 1-34 and 56-96 domains of Vpr were introduced as the restraints found between helical domains I and III and in Vpr full length and corresponding to helical domain I and II in . The 20 structures that had the lowest total energy were used for the final structural analysis. To evaluate the stability of this model, molecular dynamics simulations were done on the structure that had the lowest energy. The NMR distance restraints obtained for Vpr, and corresponding to the remaining residues in Vpr D(37-50) were used to maintain the two a-helices close to each others.
The long-range restraints introduced during the simulated annealing between helical domains I and II were removed during the molecular dynamics. The NMR restraints found in Vpr for the 35, 36, 51, 52, 53 residues were not introduced in the simulations. The model was minimized using 1000 steps of steepest descent, followed by 1000 steps of conjugate gradient and then subjected to a 250 ps molecular dynamics at 300 K with e ¼ 4r. All dynamics were carried out with a time step of 1 fs. The coordinates were saved every 5 ps.
